Authors:
DEFRANCESCHI L
ROUYERFESSARD P
ALPER SL
JOUAULT H
BRUGNARA C
BEUZARD Y
Citation: L. Defranceschi et al., COMBINATION THERAPY OF ERYTHROPOIETIN, HYDROXYUREA, AND CLOTRIMAZOLE IN A BETA-THALASSEMIC MOUSE - A MODEL FOR HUMAN THERAPY, Blood, 87(3), 1996, pp. 1188-1195
Authors:
NAFFAKH N
HENRI A
VILLEVAL JL
ROUYERFESSARD P
MOULLIER P
BLUMENFELD N
DANOS O
VAINCHENKER W
HEARD JM
BEUZARD Y
Citation: N. Naffakh et al., SUSTAINED DELIVERY OF ERYTHROPOIETIN IN MICE BY GENETICALLY-MODIFIED SKIN FIBROBLASTS, Proceedings of the National Academy of Sciences of the United Statesof America, 92(8), 1995, pp. 3194-3198
Authors:
VILLEVAL JL
ROUYERFESSARD P
BLUMENFELD N
HENRI A
VAINCHENKER W
BEUZARD Y
Citation: Jl. Villeval et al., RETROVIRUS-MEDIATED TRANSFER OF THE ERYTHROPOIETIN GENE IN HEMATOPOIETIC-CELLS IMPROVES THE ERYTHROCYTE PHENOTYPE IN MURINE BETA-THALASSEMIA, Blood, 84(3), 1994, pp. 928-933
Authors:
DEFRANCESCHI L
ROUYERFESSARD P
ALPER SL
BRUGNARA C
BEUZARD Y
Citation: L. Defranceschi et al., COMBINED THERAPEUTIC MODALITIES IN A BETA-THALASSEMIC MOUSE - A MODELFOR HUMAN BETA-THALASSEMIA, Blood, 84(10), 1994, pp. 10000363-10000363
Authors:
SAADANE N
ROUYERFESSARD P
VILLEVAL JL
BLUMENFELDCHARBIT N
HENRI A
LEROYVIARD K
SAUVAGE C
VICAUT E
MAUREL A
VAINCHENKER W
BEUZARD Y
Citation: N. Saadane et al., PHYSIOPATHOLOGICAL AND THERAPEUTIC SIGNIFICANCE OF ANIMAL-MODELS OF HEMOGLOBINOPATHIES, Nouvelle revue francaise d'hematologie, 35(3), 1993, pp. 301-302
Authors:
SCOTT MD
VANDENBERG JJM
REPKA T
ROUYERFESSARD P
HEBBEL RP
BEUZARD Y
LUBIN BH
Citation: Md. Scott et al., EFFECT OF EXCESS ALPHA-HEMOGLOBIN CHAINS ON CELLULAR AND MEMBRANE OXIDATION IN MODEL BETA-THALASSEMIC ERYTHROCYTES, The Journal of clinical investigation, 91(4), 1993, pp. 1706-1712